FDA Approved: ENJAYMO — Original Application (Recordati Rare Diseases, Inc.)

View source ↗

Summary

FDA approved ENJAYMO (sutimlimab-jome) for adults with cold agglutinin disease, marking the original approval for this therapy. The drug inhibits the classical …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cold Agglutinin Disease

Drugs mentioned

• Enjaymo (sutimlimab)

Snippet

ORIG AP for ENJAYMO (SUTIMLIMAB-JOME)